Comparison of postoperative awakening between ciprofol and propofol in elderly patients undergoing hip replacement surgery: a single-blind, randomized, controlled trial

被引:0
|
作者
Yang, Dawei [1 ]
Zhou, Jie [2 ]
Sun, Luyu [1 ]
Li, Min [1 ]
Zhang, Jianyou [1 ]
机构
[1] Yangzhou Univ, Affiliated Hosp Yangzhou Univ, Dept Anesthesiol, Yangzhou, Jiangsu, Peoples R China
[2] Yangzhou Univ, Affiliated Hosp Yangzhou Univ, Dept Obstet & Gynecol, Yangzhou, Jiangsu, Peoples R China
关键词
Aged; Arthroplasty; replacement; hip; Postoperative period; GENERAL-ANESTHESIA; INDUCTION; MAINTENANCE; MULTICENTER; EFFICACY; PHASE-3; SAFETY;
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
BACKGROUND: The aim of this paper was to compare the impact of continuous infusion of ciprofol versus propofol on postoperative awakening in elderly patients following hip replacement surgery. METHODS: Patients were randomized into two groups (N.45 each): the ciprofol group and the propofol group. The ciprofol group received ciprofol for anesthesia induction and maintenance, while the propofol group underwent anesthesia induction and maintenance using propofol. The primary outcome was awakening time. Secondary outcomes included spontaneous breathing recovery time, extubation time, time to modified Aldrete Score >9, modified observer's assessment of alertness/sedation (MOAA/S) scores, anesthetic dosage, volume of fluid replacement, urine output and administration of vasoactive drugs. RESULTS: The Ciprofol group exhibited a significantly prolonged awakening time (11.0 +/- 6.4 min vs. 7.4 +/- 4.3 min, P=0.003), spontaneous breathing recovery time (9.9 +/- 6.3 min vs. 5.9 +/- 4.3 min, P=0.001), and extubation time (12.0 [8.016.0] min vs. 8.5 [6.0-11.0] min, P=0.005), and reduced requirement for intraoperative fluid replacement (728.9 +/- 254.2 mL vs. 908.3 +/- 287.5 mL, P=0.003), increased urine output (235.1 +/- 102.1 mL vs. 173.5 +/- 106.2 mL, P=0.007), decreased likelihood of vasoactive drug administration (15/30 vs. 28/14, P=0.002). No significant differences were observed between the two groups in terms of reaching a modified Aldrete Score >9, MOAA/S scores at 0, 5, 15, or 30 minutes post-extubation, or occurrence of adverse reactions (P>0.05). The dosage of remifentanil was significantly higher in the ciprofol group [5.4 (2.7-7.4) mu gkg(-1)h(-1) vs. 3.4 (1.9-4.3) mu gkg(-1)h(-1), P0.004], with a mean maintenance dose of ciprofol at 0.8 mgkg(-1)h(-1) (range: 0.5 to 1.2 mgkg(-1)h(-1)). CONCLUSIONS: Compared to propofol, the administration of ciprofol in elderly patients following hip replacement surgery is associated with prolonged awakening time, spontaneous breathing recovery time, and extubation. The average intravenous maintenance dosage of ciprofol in geriatric patients under general anesthesia was 0.8 mgkg(-1)h(-1).
引用
收藏
页码:1074 / 1081
页数:8
相关论文
共 50 条
  • [1] Comparison of postoperative awakening between ciprofol and propofol in elderly patients undergoing hip replacement surgery: a single-blind, randomized, controlled trial
    Yang, Dawei
    Zhou, Jie
    Sun, Luyu
    Li, Min
    Zhang, Jianyou
    MINERVA ANESTESIOLOGICA, 2024,
  • [2] A Multi-Center, Single-Blind, Randomized Controlled Trial of Ciprofol and Propofol During Gastroscopy in Elderly Patients
    Zhang, Xiang
    Zhu, Tao
    ANESTHESIA AND ANALGESIA, 2024, 139 (06): : 1883 - 1884
  • [3] Postoperative quality of recovery comparison between ciprofol and propofol in total intravenous anesthesia for elderly patients undergoing laparoscopic major abdominal surgery: A randomized, controlled, double-blind, non-inferiority trial
    Liang, Zenghui
    Liu, Jing
    Chen, Shuhan
    Zhao, Xiaona
    Chen, Gezi
    Xie, Yanle
    Wang, Dongmei
    Xing, Fei
    Mao, Yuanyuan
    Zhang, Wei
    Wang, Zhongyu
    Yuan, Jingjing
    JOURNAL OF CLINICAL ANESTHESIA, 2024, 99
  • [4] A Comparison of Efficacy between Low-dose Dexmedetomidine and Propofol for Prophylaxis of Postoperative Delirium in Elderly Patients Undergoing Hip Fracture Surgery: A Randomized Controlled Trial
    Ekkapat, Gamonmas
    Kampitak, Wirinaree
    Theerasuwipakorn, Nonthikorn
    Kittipongpattana, Jirapat
    Engsusophon, Phatthanaphol
    Phannajit, Jeerath
    Chokengarmwong, Nalin
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2024, 28 (05) : 467 - 474
  • [5] Effects of edaravone on postoperative cognitive function in elderly patients undergoing hip joint replacement surgery: A randomized controlled trial
    Zhang, Nan-Nan
    Sun, Long
    Chen, Wen-Ting
    Yang, Yang-Liang
    Wu, Yi-Ming
    INTERNATIONAL JOURNAL OF SURGERY, 2020, 80 : 13 - 18
  • [6] Comparison of hypotension incidence between remimazolam and propofol in patients with hypertension undergoing neurosurgery: prospective, randomized, single-blind trial
    Choi, Seung Ho
    Min, Kyeong Tae
    Park, Eun Kyung
    Park, Sujung
    BMC ANESTHESIOLOGY, 2024, 24 (01):
  • [7] The Effect of Ciprofol on Postoperative Delirium in Elderly Patients Undergoing Thoracoscopic Surgery for Lung Cancer: A Prospective, Randomized, Controlled Trial
    Liu, Zhaohui
    Jin, Yi
    Wang, Lingfei
    Huang, Zeqing
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 325 - 339
  • [8] The efficacy and safety of ciprofol and propofol in patients undergoing colonoscopy: A double-blind, randomized, controlled trial
    Gao, Shi-Hui
    Tang, Qian-Qian
    Wang, Chang-Ming
    Guan, Zhan-Ying
    Wang, Ling-Ling
    Zhang, Jing
    Yan, Zeng-Long
    JOURNAL OF CLINICAL ANESTHESIA, 2024, 95
  • [9] Effect of deep neuromuscular blockade on serum cytokines and postoperative delirium in elderly patients undergoing total hip replacement A prospective single-blind randomised controlled trial
    Oh, Chung-Sik
    Lim, Ho Yung
    Jeon, Hong Jun
    Kim, Tae-Hoon
    Park, Hyun-Jun
    Piao, Liyun
    Kim, Seong-Hyop
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2021, 38 : S58 - S66
  • [10] Effects of Ciprofol and Propofol General Anesthesia on Postoperative Recovery Quality in Patients Undergoing Ureteroscopy: A Randomized, Controlled, Double-Blind Clinical Trial
    Shi, Shuqi
    Wu, Jimin
    Wu, Yini
    Han, Xin
    Dai, Hong
    Chen, Xuedong
    Sun, Zhangnan
    Wang, Faxing
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19 : 931 - 943